Prednisolone Metasulfobenzoate PDE report and OEL report profile
Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
CAS Registry Number
3694-41-5
Molecular formula
C28H32O9S
Molecular weight
544.61 g/mol
Drug class
Topical glucocorticoid corticosteroidprednisolone 21-metasulphobenzoate sodium salt
Mechanism of action
A water-soluble ester of prednisolone that releases or delivers the active glucocorticoid locally. Prednisolone activates intracellular glucocorticoid receptors, regulating inflammatory gene transcription and suppressing mucosal inflammatory responses.
Indications / reported uses
Rectal foam or rectal solution treatment of distal ulcerative colitis and other corticosteroid-responsive inflammatory conditions of the rectum or distal colon under the specific product label.
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Prednisolone Metasulfobenzoate PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Prednisolone Metasulfobenzoate Permitted Daily Exposure (PDE) report (the Prednisolone Metasulfobenzoate PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Prednisolone Metasulfobenzoate Occupational Exposure Limit (OEL) report (the Prednisolone Metasulfobenzoate OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.